Jong Min Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jong Min Lee has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Nam Kyu Kim
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea
10 shared publications Min Soo Cho
Department of Surgery, Severance Hospital Yonsei University College of Medicine Seoul Korea
5 shared publicationsByung Soh Min
Department of Surgery, Severance Hospital Yonsei University College of Medicine Seoul Korea
4 shared publications- Jeehye Lee
Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
4 shared publications Kang Young Lee
Department of Surgery, Severance Hospital Yonsei University College of Medicine Seoul Korea
4 shared publications- Taehyung Kim
Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
4 shared publications
Latest Publications
- 12 July 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (9) , 2570-2577
Distinct Risk Profiles for Intraoperative Blood Loss and Perioperative Transfusion in Colorectal Cancer: A Comparative Predictive Modelling Study
Background: Significant intraoperative blood loss (SIBL) and perioperative transfusion (PTF) are major concerns in colorectal cancer (CRC) surgery, yet they are often considered sequential events despite potentially distinct mechanisms. Methods: We retrospectively analysed 706 patients who underwent curative resection for non‐metastatic CRC. Logistic LASSO regression was used to identify predictors for SIBL (> 200 mL) and PTF. Model performance was evaluated using area under the curve (AUC), calibration metrics, and 1000 bootstrap validation. Results: SIBL occurred in 18.1% of patients, and PTF was required in 12.3%. Independent predictors of SIBL included rectal cancer, preoperative radio‐ or chemotherapy, and surgeon experience less than 3 years, while minimally invasive surgery was associated with a reduced risk. In contrast, predictors of PTF included haemoglobin < 10.0 g/dL, albumin < 3.5 g/dL, CEA > 5 ng/mL, congestive heart failure, and renal dysfunction. cT4 stage, concurrent resection and platelet < 100 × 10 3 /μL were common predictors in both models. The bootstrap‐validated AUCs were 0.836 for SIBL and 0.934 for PTF, with calibration slopes of 0.886 and 0.893, respectively. In sensitivity analysis, PTF model showed an AUC of 0.897 (95% CI: 0.838–0.957) in patients without preoperative transfusion and SIBL defined as > 500 mL showed an AUC of 0.843 (95% CI: 0.763–0.924). Conclusion: Our findings suggest that SIBL and PTF arise from different risk factors. SIBL reflects surgical complexity, whereas PTF reflects impaired physiological reserve. Further research is warranted to validate these models in diverse cohorts to establish preventive strategies for these adverse outcomes.
- 12 July 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (9) , 2570-2577
Distinct Risk Profiles for Intraoperative Blood Loss and Perioperative Transfusion in Colorectal Cancer: A Comparative Predictive Modelling Study
Background: Significant intraoperative blood loss (SIBL) and perioperative transfusion (PTF) are major concerns in colorectal cancer (CRC) surgery, yet they are often considered sequential events despite potentially distinct mechanisms. Methods: We retrospectively analysed 706 patients who underwent curative resection for non‐metastatic CRC. Logistic LASSO regression was used to identify predictors for SIBL (> 200 mL) and PTF. Model performance was evaluated using area under the curve (AUC), calibration metrics, and 1000 bootstrap validation. Results: SIBL occurred in 18.1% of patients, and PTF was required in 12.3%. Independent predictors of SIBL included rectal cancer, preoperative radio‐ or chemotherapy, and surgeon experience less than 3 years, while minimally invasive surgery was associated with a reduced risk. In contrast, predictors of PTF included haemoglobin < 10.0 g/dL, albumin < 3.5 g/dL, CEA > 5 ng/mL, congestive heart failure, and renal dysfunction. cT4 stage, concurrent resection and platelet < 100 × 10 3 /μL were common predictors in both models. The bootstrap‐validated AUCs were 0.836 for SIBL and 0.934 for PTF, with calibration slopes of 0.886 and 0.893, respectively. In sensitivity analysis, PTF model showed an AUC of 0.897 (95% CI: 0.838–0.957) in patients without preoperative transfusion and SIBL defined as > 500 mL showed an AUC of 0.843 (95% CI: 0.763–0.924). Conclusion: Our findings suggest that SIBL and PTF arise from different risk factors. SIBL reflects surgical complexity, whereas PTF reflects impaired physiological reserve. Further research is warranted to validate these models in diverse cohorts to establish preventive strategies for these adverse outcomes.
- Open Access
- 18 June 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1865242
Which immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison
Background: Many immunonutritional markers (INMs) have emerged as significant prognostic indicators in colorectal cancer (CRC); however, limited attention has been given to directly comparing these candidates to identify the most informative predictors. Methods: We retrospectively analyzed 414 patients with stage I–III CRC who underwent curative resection. Seven INMs, including the C-reactive protein-albumin-lymphocyte (CALLY) index, the C-reactive protein-to-albumin ratio (CAR), and five other markers, were evaluated. The primary outcome was disease-free survival (DFS). Multivariable Cox proportional hazards regression was performed to identify independent predictors of DFS. The discriminatory performance of the resulting models was quantified using Harrell’s concordance index (C-index). Results: In univariable analysis, all seven INMs were significantly associated with DFS. However, after adjusting for T and N stages and other covariates, only the CALLY index (HR, 1.686; 95% confidence interval (CI), 1.038–2.738; p = 0.035) and CAR (HR, 2.089; 95% CI, 1.276–3.422; p = 0.004) remained independent predictors. Integrating these markers into the staging system significantly enhanced predictive accuracy. The C-index improved from 0.713 (95% CI, 0.657–0.764) for the stage-only model to 0.812 (95% CI, 0.781–0.867) for the CALLY + stage model and 0.809 (95% CI, 0.779–0.865) for the CAR + stage model. Conclusion: The CALLY index and CAR were the only INMs that retained independent prognostic significance after adjustment for T and N stages. Incorporating these continuous markers into the Tumor-Node-Metastasis (TNM) staging system substantially improved risk stratification and predictive accuracy in patients with non-metastatic CRC.
- 18 June 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1865242
Open AccessWhich immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison
Background: Many immunonutritional markers (INMs) have emerged as significant prognostic indicators in colorectal cancer (CRC); however, limited attention has been given to directly comparing these candidates to identify the most informative predictors. Methods: We retrospectively analyzed 414 patients with stage I–III CRC who underwent curative resection. Seven INMs, including the C-reactive protein-albumin-lymphocyte (CALLY) index, the C-reactive protein-to-albumin ratio (CAR), and five other markers, were evaluated. The primary outcome was disease-free survival (DFS). Multivariable Cox proportional hazards regression was performed to identify independent predictors of DFS. The discriminatory performance of the resulting models was quantified using Harrell’s concordance index (C-index). Results: In univariable analysis, all seven INMs were significantly associated with DFS. However, after adjusting for T and N stages and other covariates, only the CALLY index (HR, 1.686; 95% confidence interval (CI), 1.038–2.738; p = 0.035) and CAR (HR, 2.089; 95% CI, 1.276–3.422; p = 0.004) remained independent predictors. Integrating these markers into the staging system significantly enhanced predictive accuracy. The C-index improved from 0.713 (95% CI, 0.657–0.764) for the stage-only model to 0.812 (95% CI, 0.781–0.867) for the CALLY + stage model and 0.809 (95% CI, 0.779–0.865) for the CAR + stage model. Conclusion: The CALLY index and CAR were the only INMs that retained independent prognostic significance after adjustment for T and N stages. Incorporating these continuous markers into the Tumor-Node-Metastasis (TNM) staging system substantially improved risk stratification and predictive accuracy in patients with non-metastatic CRC.
- Open Access
- 28 February 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (1) , 4-33
The Korean Rectal Cancer Multidisciplinary Committee Clinical Practice Guidelines for Rectal Cancer version 2.0
Rectal cancer, which accounts for approximately 40% of colorectal cancers, remains a major clinical concern. Recent advances in diagnostic imaging, surgical techniques, radiotherapy, and systemic treatment have steadily improved rectal cancer outcomes. Considering this, the Korean Rectal Cancer Multidisciplinary (KRCM) Committee has aimed to provide clinicians and policymakers with up-to-date, evidence-based clinical practice guidelines to support optimal decision-making, reflecting current evidence, the Korean healthcare context, and patient values and preferences. The Clinical Practice Guidelines for Rectal Cancer version 2.0 were developed through multidisciplinary collaboration with related academic societies, building upon and updating the KRCM Clinical Practice Guidelines version 1.0 (titled “Multidisciplinary guidelines for the management of rectal cancer”). These consensus guidelines of the KRCM were established based on a comprehensive literature review, evidence synthesis, with recommendation development guided by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, and consideration of applicability in real-world clinical practice under the national health insurance system. Each recommendation has been presented with its strength and level of evidence.
- 28 February 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (1) , 4-33
Open AccessThe Korean Rectal Cancer Multidisciplinary Committee Clinical Practice Guidelines for Rectal Cancer version 2.0
Rectal cancer, which accounts for approximately 40% of colorectal cancers, remains a major clinical concern. Recent advances in diagnostic imaging, surgical techniques, radiotherapy, and systemic treatment have steadily improved rectal cancer outcomes. Considering this, the Korean Rectal Cancer Multidisciplinary (KRCM) Committee has aimed to provide clinicians and policymakers with up-to-date, evidence-based clinical practice guidelines to support optimal decision-making, reflecting current evidence, the Korean healthcare context, and patient values and preferences. The Clinical Practice Guidelines for Rectal Cancer version 2.0 were developed through multidisciplinary collaboration with related academic societies, building upon and updating the KRCM Clinical Practice Guidelines version 1.0 (titled “Multidisciplinary guidelines for the management of rectal cancer”). These consensus guidelines of the KRCM were established based on a comprehensive literature review, evidence synthesis, with recommendation development guided by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, and consideration of applicability in real-world clinical practice under the national health insurance system. Each recommendation has been presented with its strength and level of evidence.
- Open Access
- 7 January 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Association between metabolic dysfunction-associated steatotic liver disease and breast cancer risk in Korean women: a nationwide population-based cohort study
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disorder linked to systemic metabolic imbalance. Although MASLD
- 7 January 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Open AccessAssociation between metabolic dysfunction-associated steatotic liver disease and breast cancer risk in Korean women: a nationwide population-based cohort study
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disorder linked to systemic metabolic imbalance. Although MASLD
- Open Access
Heterogeneous Colorectal Cancer Risk in Women with Metabolic Dysfunction-Associated Steatotic Liver Disease by Age, Lipid, and Waist-Circumference: A Nationwide Cohort Study
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly common and linked to obesity; however, its association with colorectal cancer (CRC) risk in women remains unclear. Materials and Methods: This retrospective cohort study used the Korean National Health Insurance Service health-screening database, including 483,401 women aged 40–59 years examined between 2013 and 2016, followed through 2021. MASLD was defined as hepatic steatosis (hepatic steatosis index ≥ 36 or ICD-10 K76.0) with ≥1 metabolic abnormality and no heavy alcohol use (≥20 g/day). Incident CRC (ICD-10 C18–C20) was analyzed using Cox regression adjusted for demographic, socioeconomic, and metabolic variables. Effect modification was tested across key covariates. Results: MASLD was found in 128,642 participants (26.6%). During a median 7.5-year follow-up, 2432 CRC cases occurred (702 with MASLD). The 7-year cumulative CRC risk was higher in the MASLD group (0.47% vs. 0.43%; p = 0.006). MASLD independently increased CRC risk (adjusted HR 1.10; 95% CI 1.00–1.20). Effect modification was observed for age, dyslipidemia, and waist circumference. MASLD significantly increased CRC risk among women aged 40–49 years (HR 1.26; 95% CI 1.05–1.49), those without dyslipidemia (HR 1.15; 95% CI 1.03–1.28), and with waist < 85 cm (HR 1.15; 95% CI 1.02–1.30). Conclusions: MASLD modestly increases CRC risk in Korean women, particularly among younger, normolipidemic, and non-obese individuals, indicating the need for age- and metabolism-specific risk stratification and suggesting a need for closer clinical attention and metabolic optimization.
Open AccessHeterogeneous Colorectal Cancer Risk in Women with Metabolic Dysfunction-Associated Steatotic Liver Disease by Age, Lipid, and Waist-Circumference: A Nationwide Cohort Study
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly common and linked to obesity; however, its association with colorectal cancer (CRC) risk in women remains unclear. Materials and Methods: This retrospective cohort study used the Korean National Health Insurance Service health-screening database, including 483,401 women aged 40–59 years examined between 2013 and 2016, followed through 2021. MASLD was defined as hepatic steatosis (hepatic steatosis index ≥ 36 or ICD-10 K76.0) with ≥1 metabolic abnormality and no heavy alcohol use (≥20 g/day). Incident CRC (ICD-10 C18–C20) was analyzed using Cox regression adjusted for demographic, socioeconomic, and metabolic variables. Effect modification was tested across key covariates. Results: MASLD was found in 128,642 participants (26.6%). During a median 7.5-year follow-up, 2432 CRC cases occurred (702 with MASLD). The 7-year cumulative CRC risk was higher in the MASLD group (0.47% vs. 0.43%; p = 0.006). MASLD independently increased CRC risk (adjusted HR 1.10; 95% CI 1.00–1.20). Effect modification was observed for age, dyslipidemia, and waist circumference. MASLD significantly increased CRC risk among women aged 40–49 years (HR 1.26; 95% CI 1.05–1.49), those without dyslipidemia (HR 1.15; 95% CI 1.03–1.28), and with waist < 85 cm (HR 1.15; 95% CI 1.02–1.30). Conclusions: MASLD modestly increases CRC risk in Korean women, particularly among younger, normolipidemic, and non-obese individuals, indicating the need for age- and metabolism-specific risk stratification and suggesting a need for closer clinical attention and metabolic optimization.
- Open Access
- 23 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8324
Single-Shot Subcutaneous Lidocaine Infiltration at Closure Is Associated with Reduced Early Pain and Opioid Requirement After Single-Incision Laparoscopic Totally Extraperitoneal Hernia Repair
Background: Subcutaneous wound infiltration with local anesthetics has been proposed as a simple adjunct for postoperative pain control; however, its value in single-incision laparoscopic total extraperitoneal (SILTEP) inguinal hernia repair remains unclear. Methods: We retrospectively analyzed 199 consecutive SILTEP inguinal hernia repairs performed between November 2022 and July 2025 (117 no-lidocaine, 82 lidocaine). A double adjustment, combining 1:1 propensity score matching with multivariable regression across 20 multiply imputed datasets was performed. The primary outcome was maximal numeric pain intensity scale (NPIS) on postoperative day (POD) 0. Results: Eighty-two matched pairs were generated. In the final pooled, adjusted models, lidocaine infiltration was associated with a significant reduction in the primary outcome, maximal NPIS on POD 0 (β = −1.25; 95% CI: −2.01 to −0.50; p = 0.001). Lidocaine was also associated with significantly lower odds of requiring rescue analgesia on POD 0 (OR = 0.12; 95% CI: 0.03–0.46; p = 0.002), fewer rescue doses during hospitalization (β = −1.11; 95% CI: −1.62 to −0.49; p < 0.001), and a lower morphine-equivalent dose (β = −5.14; 95% CI: −7.79 to −2.49; p < 0.001). No increase in postoperative complications was observed. Conclusions: Single-shot subcutaneous lidocaine infiltration in SILTEP hernia repair is a simple, low-risk intervention that was associated with reduced immediate postoperative pain and opioid use without increasing complications. However, the effect was short-lived with no sustained benefit beyond the first postoperative day.
- 23 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8324
Open AccessSingle-Shot Subcutaneous Lidocaine Infiltration at Closure Is Associated with Reduced Early Pain and Opioid Requirement After Single-Incision Laparoscopic Totally Extraperitoneal Hernia Repair
Background: Subcutaneous wound infiltration with local anesthetics has been proposed as a simple adjunct for postoperative pain control; however, its value in single-incision laparoscopic total extraperitoneal (SILTEP) inguinal hernia repair remains unclear. Methods: We retrospectively analyzed 199 consecutive SILTEP inguinal hernia repairs performed between November 2022 and July 2025 (117 no-lidocaine, 82 lidocaine). A double adjustment, combining 1:1 propensity score matching with multivariable regression across 20 multiply imputed datasets was performed. The primary outcome was maximal numeric pain intensity scale (NPIS) on postoperative day (POD) 0. Results: Eighty-two matched pairs were generated. In the final pooled, adjusted models, lidocaine infiltration was associated with a significant reduction in the primary outcome, maximal NPIS on POD 0 (β = −1.25; 95% CI: −2.01 to −0.50; p = 0.001). Lidocaine was also associated with significantly lower odds of requiring rescue analgesia on POD 0 (OR = 0.12; 95% CI: 0.03–0.46; p = 0.002), fewer rescue doses during hospitalization (β = −1.11; 95% CI: −1.62 to −0.49; p < 0.001), and a lower morphine-equivalent dose (β = −5.14; 95% CI: −7.79 to −2.49; p < 0.001). No increase in postoperative complications was observed. Conclusions: Single-shot subcutaneous lidocaine infiltration in SILTEP hernia repair is a simple, low-risk intervention that was associated with reduced immediate postoperative pain and opioid use without increasing complications. However, the effect was short-lived with no sustained benefit beyond the first postoperative day.
- Open Access
- 5 February 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (4) , 2262-2267
Innovative articulating instruments in single incision laparoscopic totally extraperitoneal hernioplasty (SILTEP): Evaluating feasibility, safety, and learning curve
- 5 February 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (4) , 2262-2267
Open AccessInnovative articulating instruments in single incision laparoscopic totally extraperitoneal hernioplasty (SILTEP): Evaluating feasibility, safety, and learning curve
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (12) , 891-896
Long-Term Outcomes of Long-Course Chemoradiotherapy vs. Short-Course Radiotherapy Followed by Consolidation Chemotherapy in Rectal Cancer
Lee JM, et al. Yonsei Med J. 2025 Dec;66(12):891-896. https://doi.org/10.3349/ymj.2025.0216
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (12) , 891-896
Open AccessLong-Term Outcomes of Long-Course Chemoradiotherapy vs. Short-Course Radiotherapy Followed by Consolidation Chemotherapy in Rectal Cancer
Lee JM, et al. Yonsei Med J. 2025 Dec;66(12):891-896. https://doi.org/10.3349/ymj.2025.0216